Checkpoint Therapeutics Inc (CKPT)
3.75
+0.28
(+8.07%)
USD |
NASDAQ |
Nov 22, 16:00
3.72
-0.03
(-0.80%)
After-Hours: 20:00
Checkpoint Therapeutics Shareholders Equity (Quarterly): -12.59M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -12.59M |
| June 30, 2024 | -15.75M |
| March 31, 2024 | -10.25M |
| December 31, 2023 | -13.05M |
| September 30, 2023 | -19.04M |
| June 30, 2023 | -23.27M |
| March 31, 2023 | -22.18M |
| December 31, 2022 | -19.48M |
| September 30, 2022 | -1.335M |
| June 30, 2022 | 7.462M |
| March 31, 2022 | 20.22M |
| December 31, 2021 | 29.75M |
| September 30, 2021 | 47.97M |
| June 30, 2021 | 56.87M |
| March 31, 2021 | 54.18M |
| December 31, 2020 | 35.38M |
| September 30, 2020 | 36.22M |
| Date | Value |
|---|---|
| June 30, 2020 | 14.97M |
| March 31, 2020 | 16.22M |
| December 31, 2019 | 18.85M |
| September 30, 2019 | 6.269M |
| June 30, 2019 | 7.209M |
| March 31, 2019 | 7.078M |
| December 31, 2018 | 11.81M |
| September 30, 2018 | 22.02M |
| June 30, 2018 | 22.30M |
| March 31, 2018 | 28.90M |
| December 31, 2017 | 15.04M |
| September 30, 2017 | 19.82M |
| June 30, 2017 | 24.84M |
| March 31, 2017 | 28.90M |
| December 31, 2016 | 32.30M |
| September 30, 2016 | 35.49M |
| December 31, 2015 | 46.40M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-23.27M
Minimum
Jun 2023
56.87M
Maximum
Jun 2021
10.06M
Average
11.22M
Median
Shareholders Equity (Quarterly) Benchmarks
| Fortress Biotech Inc | 21.16M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.179M |
| Total Liabilities (Quarterly) | 17.77M |